Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2011 1
2013 2
2017 1
2018 1
2020 1
2021 2
2022 74
2023 16
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 36878550

94 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
Ng OT, Marimuthu K, Lim N, Lim ZQ, Thevasagayam NM, Koh V, Chiew CJ, Ma S, Koh M, Low PY, Tan SB, Ho J, Maurer-Stroh S, Lee VJM, Leo YS, Tan KB, Cook AR, Tan CC. Ng OT, et al. JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900. JAMA Netw Open. 2022. PMID: 36018588 Free PMC article.
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.
Al Kaabi N, Yang Y, Eldin Hussein S, Yang T, Abdalla J, Wang H, Lou Z, Chinese Center For Disease Control And Prevention, Bakkour A, Arafat A, China National Biotec Group Company Limited, Jiang Z, Tian Y, National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd, Beijing Institute Of Biological Products Company Limited, Xiao P, Zaher W, Eltantawy I, Wang C, Xu G, Zhang Y, Yang X. Al Kaabi N, et al. Vaccines (Basel). 2023 Jan 30;11(2):299. doi: 10.3390/vaccines11020299. Vaccines (Basel). 2023. PMID: 36851177 Free PMC article.
Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
Zhang Y, Ma X, Yan G, Wu Y, Chen Y, Zhou Z, Wan N, Su W, Liu FW, Dai MX, Yang M, Li C, Yu X, Zhang L, Wang Z, Zhou TC, You D, Wei J, Zhang Z; Precise-CoVaccine study group. Zhang Y, et al. EClinicalMedicine. 2022 Sep 28;54:101680. doi: 10.1016/j.eclinm.2022.101680. eCollection 2022 Dec. EClinicalMedicine. 2022. PMID: 36188435 Free PMC article.
94 results